Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Anthera Pharmaceuticals logo — Pioneering Therapeutics to Combat Inflammatory Diseases, Pio...

Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Founded 2004 Post-IPO Equity Total: $101.50M Biotechnology, Health Care +1

General Information

Company Name Anthera Pharmaceuticals
Founded Year 2004
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Anthera Pharmaceuticals. To contact Anthera Pharmaceuticals, visit anthera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Anthera Pharmaceuticals compare?

A PDF of Anthera Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Anthera Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Anthera Pharmaceuticals

Anthera Pharmaceuticals, founded in 2004, is a development stage biopharmaceutical company with a focus on creating and bringing to market therapeutics for inflammation-related diseases. The company's main product candidates, including varespladib methyl (A-002) and varespladib sodium (A-001), target cardiovascular and autoimmune disorders. Anthera Pharmaceuticals holds license agreements with Eli Lilly and Company, Shionogi & Co., Ltd., and Amgen Inc. to develop and commercialize treatments for various diseases. With a last investment of $15.00M in post-IPO equity at 10 January 2018, the company is headquartered in Hayward, California. Anthera Pharmaceuticals is pioneering therapeutics to combat inflammatory diseases and aiming to pioneer better health in the biotechnology, healthcare, and pharmaceutical industries.

Business keywords: Biopharmaceutical, Therapeutics, Inflammatory Diseases, Cardiovascular Disorders, Autoimmune Disorders, Clinical Trials, Drug Development, B-cell Mediated Autoimmune Diseases, Sickle Cell Disease, Eli Lilly and Company, Shionogi & Co., Ltd., Amgen Inc., Healthcare Innovation, Research and Development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $15.00M -
10 Jan 2018
Post IPO Debt Undisclosed 1
Hercules Capital
Hercules Capital
01 Jan 2011
Post IPO Equity $31.50M 2
OrbiMed Caxton Associates
OrbiMed, Caxton Associates
21 Sep 2010
Venture Round $19.00M 6
HBM Healthcare Investments Sofinnova Investments VantagePoint Capital Partners
HBM Healthcare Investments, Sofinnova Investments +4
14 Aug 2008
Venture Round $36.00M 1
Sofinnova Investments
Sofinnova Investments
13 Sep 2006

Anthera Pharmaceuticals Alternatives & Competitors

View All Alternatives
Anthera Pharmaceuticals vs
Hypnion
Hypnion

Advancing neuroscience to enhance sleep and wake-alertness with innovative treatments for CNS disord...

Series B
Biotechnology, Health Care
Anthera Pharmaceuticals vs
IpiNovyx Bio
IpiNovyx Bio United States

We are a drug platform focused on treating autoimmune and inflammatory diseases.

Seed
6 employees
Biopharma, Biotechnology
Anthera Pharmaceuticals vs
Alvine Pharmaceuticals
Alvine Pharmaceuticals

Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment for celia...

Debt Financing
1 employees
Biotechnology, Health and Wellness
Also compare with: Anthera Pharmaceuticals vs Emmaus Life Sciences, Inc Emmaus Life Sciences, Inc View all alternatives

FAQ About Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health
Anthera Pharmaceuticals was founded in 2004.
Anthera Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Biopharmaceutical, Therapeutics, Inflammatory Diseases and Cardiovascular Disorders.
Anthera Pharmaceuticals has completed 5 funding rounds, raising a total of $101.50M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Anthera Pharmaceuticals include Hypnion, IpiNovyx Bio, Alvine Pharmaceuticals, Molecules For Health Inc, Artax Biopharma Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anthera Pharmaceuticals and Hypnion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Anthera Pharmaceuticals, https://bouncewatch.com/company/anthera-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout